IRIDEX Co. (NASDAQ: IRIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
Ophthalmic Lasers Market, Competitive Landscape and Market Forecasts to 2030 [Yahoo! Finance]
IRIDEX Co. (NASDAQ: IRIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
IRIDEX Co. (NASDAQ: IRIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.